Atorvastatin Effect on Reduction of COPD Exacerbations

Clinical trial NCT04789057 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04789057
Sponsor: Medical University of Bialystok
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Copd COPD Exacerbation Smoking Gene Expression Atorvastatin

Start date: 2022-02-11
Primary completion: 2026-12-31
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.